These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31487713)

  • 1. Intra-Dialytic Hemoglobin Changes and Cardiovascular Events: A Cohort Study on Dialysis Outcomes and Practice Patterns in Japan.
    Hara T; Kimachi M; Ikenoue T; Akizawa T; Fukuhara S; Yamamoto Y
    Am J Nephrol; 2019; 50(4):272-280. PubMed ID: 31487713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between Hemoglobin Levels Corrected by Interdialytic Weight Gain and Mortality in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study.
    Toida T; Iwakiri T; Sato Y; Komatsu H; Kitamura K; Fujimoto S
    PLoS One; 2017; 12(1):e0169117. PubMed ID: 28046068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of the difference in hemoglobin levels before and after hemodialysis with the risk of 1-year mortality in patients undergoing hemodialysis. Results from a nationwide cohort study of the Japanese Renal Data Registry.
    Nishiwaki H; Hasegawa T; Koiwa F; Hamano T; Masakane I
    PLoS One; 2019; 14(1):e0210533. PubMed ID: 30629677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemoglobin concentration and survival of haemodialysis patients before and after experiencing cardiovascular disease: a cohort study from Japanese dialysis outcomes and practice pattern study (J-DOPPS).
    Kido R; Akizawa T; Fukuhara S
    BMJ Open; 2019 Sep; 9(9):e031476. PubMed ID: 31492794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood Hemoglobin Concentrations and the Incidence of Lower Extremity Peripheral Arterial Disease in Patients Undergoing Hemodialysis: 10-Year Outcomes of the Q-Cohort Study.
    Kohara C; Yamada S; Tanaka S; Hiyamuta H; Kitamura H; Arase H; Shimamoto S; Taniguchi M; Tsuruya K; Kitazono T; Nakano T
    J Am Heart Assoc; 2024 Aug; 13(15):e033853. PubMed ID: 39101503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis.
    Sumida K; Diskin CD; Molnar MZ; Potukuchi PK; Thomas F; Lu JL; Rhee CM; Streja E; Yamagata K; Kalantar-Zadeh K; Kovesdy CP
    Am J Nephrol; 2017; 46(5):397-407. PubMed ID: 29130991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients.
    Bae MN; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK
    PLoS One; 2015; 10(11):e0143348. PubMed ID: 26588085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between post-dialysis hemoglobin level and the survival of vascular access.
    Nishiwaki H; Hasegawa T; Ikenoue T; Tominaga N; Yazawa M; Kawarazaki H; Shibagaki Y; Yamamoto Y; Fukuma S; Yamazaki S; Fukuhara S
    J Vasc Access; 2018 Jan; 19(1):69-75. PubMed ID: 29076517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body Mass Index Change and Hospitalization Risk in Elderly Hemodialysis Patients: Results from Japanese Dialysis Outcomes and Practice Patterns Study.
    Sumida K; Yamamoto S; Akizawa T; Fukuhara S; Fukuma S
    Am J Nephrol; 2018; 47(1):48-56. PubMed ID: 29393094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Korean Clinical Research Center for End-Stage Renal Disease Study Validates the Association of Hemoglobin and Erythropoiesis-Stimulating Agent Dose with Mortality in Hemodialysis Patients.
    Kwon O; Jang HM; Jung HY; Kim YS; Kang SW; Yang CW; Kim NH; Choi JY; Cho JH; Kim CD; Kim YL; Park SH;
    PLoS One; 2015; 10(10):e0140241. PubMed ID: 26452232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradialytic ultrafiltration volume and vascular access outcomes: a Japan Dialysis Outcomes and Practice Patterns Study subanalysis.
    Asano M; Oguchi K; Saito A; Onishi Y; Yamamoto Y; Fukuhara S; Akiba T; Akizawa T
    J Vasc Access; 2016 Nov; 17(6):489-493. PubMed ID: 27646928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salt Intake and All-Cause Mortality in Hemodialysis Patients.
    Ikenoue T; Koike K; Fukuma S; Ogata S; Iseki K; Fukuhara S
    Am J Nephrol; 2018; 48(2):87-95. PubMed ID: 30086543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA CLinical Evidence on Renal Survival in CKD patients with renal anemia (MIRACLE-CKD Study).
    Hayashi T; Uemura Y; Kumagai M; Kimpara M; Kanno H; Ohashi Y;
    Clin Exp Nephrol; 2019 Mar; 23(3):349-361. PubMed ID: 30291472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ankle brachial pressure index but not brachial-ankle pulse wave velocity is a strong predictor of systemic atherosclerotic morbidity and mortality in patients on maintenance hemodialysis.
    Tanaka M; Ishii H; Aoyama T; Takahashi H; Toriyama T; Kasuga H; Takeshita K; Yoshikawa D; Amano T; Murohara T
    Atherosclerosis; 2011 Dec; 219(2):643-7. PubMed ID: 22018643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Serum n-6 Polyunsaturated Fatty Acid Profile and Risks of Mortality and Cardiovascular Events in a Cohort of Hemodialysis Patients.
    Kuwamura Y; Shoji T; Okute Y; Yamazaki Y; Motoyama K; Morioka T; Mori K; Fukumoto S; Tsujimoto Y; Shioi A; Emoto M; Inaba M
    J Ren Nutr; 2018 Jan; 28(1):54-63. PubMed ID: 29089279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra- and post-dialytic changes of haemoglobin concentrations in non-anaemic haemodialysis patients.
    Minutolo R; De Nicola L; Bellizzi V; Iodice C; Rubino R; Aucella F; Stallone C; Nappi F; Avella F; Maione E; Conte G; Di Iorio BR
    Nephrol Dial Transplant; 2003 Dec; 18(12):2606-12. PubMed ID: 14605285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
    Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
    Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association between Dialysis Dose and Risk of Cancer Death in Patients Undergoing Hemodialysis: The Q-Cohort Study.
    Hara M; Tanaka S; Taniguchi M; Fujisaki K; Torisu K; Nakano T; Tsuruya K; Kitazono T
    Intern Med; 2020 May; 59(9):1141-1148. PubMed ID: 32051383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.